Italia markets open in 6 hours 28 minutes
Dow Jones
39.308,00 -23,90 (-0,06%) Nasdaq
18.188,30 +159,54 (+0,88%) Nikkei 225
40.829,06 +248,30 (+0,61%) EUR/USD
1,0792 +0,0005 (+0,04%) Bitcoin EUR
55.887,52 -1.707,59 (-2,96%) CMC Crypto 200
1.262,01 -72,91 (-5,46%)
SWTX Dec 2025 40.000 put
OPR - OPR Prezzo differito. Valuta in USD.
Aggiungi a watchlist
Alla chiusura: 03:58PM EDT
| Chiusura precedente | 9,00 |
| Aperto | 9,80 |
| Denaro | 9,00 |
| Domanda | 14,00 |
| Prezzo d'esercizio | 40,00 |
| Scadenza | 2025-12-19 |
| Min-Max giorno | 9,00 - 9,00 |
| Contratto - Min-Max | N/D |
| Volume | |
| Open Interest | 143 |
GlobeNewswireSpringWorks Therapeutics Reports Second Quarter 2023 Financial Results and Recent Business Highlights
– Presented additional Phase 3 DeFi data at ASCO demonstrating clinically significant reductions in pain and substantial reductions in tumor volume and T2 hyperintensity with nirogacestat treatment – – Completed enrollment of Phase 2 trial evaluating nirogacestat in patients with ovarian granulosa cell tumors – – Highlighted encouraging Phase 1 and 2 clinical data from emerging pipeline programs at AACR and EHA – STAMFORD, Conn., Aug. 02, 2023 (GLOBE NEWSWIRE) -- SpringWorks Therapeutics, Inc. (
© 2024 Yahoo. Tutti i diritti riservati.